Hundreds of mental health patients privately ‘warehoused’ far from home
Hundreds of mental health patients are being ‘warehoused’ in privately-run premises hundreds of miles from home, a BMA investigation has revealed. The investigation uncovered a...
Adults with lymphoma treated with CAR T therapy
Adults with lymphoma treated with CAR T therapy at King’s College Hospital. The hospital in south London has become the first in the UK...
72% of Scots affected by cardiovascular disease
72% of Scots have been affected by cardiovascular disease (CVD), Scotland’s biggest killer, a new survey has revealed. Research by national charity Heart Research UK...
New treatment option for uveitis recommended by NICE
A new treatment option for an inflammatory eye condition has been recommended by NICE. People with recurrent non-infectious uveitis affecting the back of the eye...
Working with the NHS: ABPI and NHS Confederation report
NHS Confederation and ABPI have launched a new report, Working with the NHS, in a drive to promote NHS-industry collaboration. The NHS Confederation and Association...
Trust in medical experts and vaccines – new research
The world’s biggest survey into public attitudes to health and science has been published, revealing high overall global trust in medical experts and vaccines. Wellcome...
Suppliers of antidepressants accused of illegal anti-competitive conduct
Suppliers of antidepressants accused of illegal anti-competitive conduct by the Competition and Markets Authority (CMA). The CMA has provisionally found that four pharmaceutical companies broke...
Quicker access to the Summary Care Record for community pharmacies
Pharmacists can now access vital patient information quickly and simply through a new Summary Care Record 1-click function. The 1-click function allows pharmacy professionals logged...
Lynparza approved in EU for BRCA-mutated advanced ovarian cancer
AstraZeneca and MSD have announced that the European Commission (EC) has approved Lynparza (olaparib) as a 1st-line maintenance treatment for women with BRCA-mutated advanced...
Sanofi and Google to develop new healthcare Innovation Lab
Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered...
Latest articles
Big Sugar and neglect by global health community fuel oral health crisis
Oral health has been isolated from traditional healthcare and health policy for too long, despite the major global public health burden of oral diseases,...
New statistics show decrease in animals used for R&D
The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out...
New insight into microRNA function can give gene therapy a boost
New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford. They have shown that...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Gene silencing therapy for hereditary amyloidosis approved by NICE
NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis. RNA interference (RNAi) therapeutics company, Alnylam UK Limited has welcomed a decision from the...
AstraZeneca to appeal NICE’s osimertinib decision
AstraZeneca to appeal NICE's osimertinib decision following it not being recommended for use within NHS England. AstraZeneca will appeal a decision by the National Institute...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
How to write a standout CV
The job market is getting more competitive by the day, as highly-qualified candidates fiercely compete for the top jobs. A carefully constructed CV is...